Jeremy Sullivan talks to CNBC Asia regarding the NZX, interest rates and the outlook for 2016 Click here to view the video

Pacific Edge Ltd is a NZX listed [PEB.NZX], New Zealand based biotechnology firm, specialising in the field of bladder cancer detection, through their primary product suite called ‘CX-Bladder’. The technology has been derived from the University of Otago and was established in 2001. The primary competitive advantage of the CX-Bladder product suite; is the non-invasive (urine) testing and their market leading diagnostic accuracy, compared to other urine based testing. The incumbent diagnostic tool is cystoscopy, which involves having a narrow tube...

Results season is over for most of New Zealand's publicly listed companies. They have fronted up to hard-eyed shareholders, laying bare their performance for the six months to December 31. A few have dazzled the crowds, a few have flopped, and many more have not moved the needle at all. The NZX is a small part of the broader economy, but the fortunes of our listed corporates provide another clue into how the country is faring. While tourism is a shining...

Shareholders gave Arvida [NZX: ARV] a tick of approval this week after a development update. Grant Davies of sharebrokers Hamilton Hindin Greene says the update from the NZX-listed retirement company was viewed positively by shareholders who have seen the share price trade at a discount to asset backing for a year or so now. Shares rose from 89c to 91c, shy of earlier levels in January of 93c a share, which compares with its December 2014 listing debut at 95c...

Jeremy Sullivan of Hamilton Hindin Greene and NBR's Duncan Bridgeman discuss this week's share market news ANZ Bank [NZX: ANZ] this week flagged global credit risk as a headwind for the banking sector, warning wholesale funding costs will probably increase. However, there are other forces at play buffeting banking stocks. Jeremy Sullivan, an analyst at Hamilton Hindin Greene, told NBR Radio’s Andrew Patterson he believes increasing regulation from across the Tasman is driving much of the negativity among investors. “Essentially, as...

Sky Network Television’s [NZX:SKT] strong cashflows should continue to reward investors with solid dividends in the short term even as the company spends up in response to competition. The key question looking further out is whether the company can convince the public that its expensive product upgrade is good enough, Hamilton Hindin Greene investment advisor Grant Davies told NBR Radio’s Andrew Patterson. “I think Sky TV will do everything in their power to maintain that gross dividend yield, which at...

HHG is proud to have won the 2015 National Business Review stock pickers award with an average return of 16.18%. Contact an advisor on 0800 10 40 50 to find out our picks for 2016

Click on the link to hear the NBR radio interview. 3m34s The New Zealand share market retreated again today, following intense volatility on Wall Street and other markets last week, cheap oil and scepticism over the Chinese economy. But the sell-off of local shares was less severe than anticipated perhaps, after last week’s global turmoil. The S&P/NZX 50 index was down nearly 2% this morning at 6055 – the lowest level since December 16. However, by 3pm the index had...

Hamilton Hinden Greene Investment Advisor, Grant Davies, comments on the year ahead on goodreturns.co.nz by Susan Edmunds The NZX finished 2015 13.5% up on the same time in 2014. It follows three years of 20%-plus returns. Mark Lister, of Craigs Investment Partners, said he expected this year to be another strong one, although he said it was likely the local market would produce a percentage return in the mid-to-high single digits, rather than stretching into double digits again. “Strong gains will...